AD

Aniket Dhingra

Active Director Director DIN 08660951
DIN 08660951 First appointment Jan 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Jan 2020
Shareholding value •••• Premium profile

About Aniket Dhingra

Data last updated:

Aniket Dhingra is a Director at Penam Biosciences Private Limited (since 2020), Director at Protech Remedies Private Limited (since 2023) and Director at S K S Metals Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Pharma, Paper and Metals and Minerals. The 2 current companies with reported revenue have a combined latest revenue of ₹42.38 Cr; the largest is Penam Biosciences Private Limited at ₹25.87 Cr (FY 2024). Earlier, Aniket Dhingra was a Designated Partner at Emriz Healthcare Llp (2026) and Director at Protech Distribution Private Limited (2024–2026).

DIN 08660951
Primary Designation Director
Industry Pharma
First Appointment 07 Jan 2020
Oldest Company Age 17 yrs
Largest company Penam Biosciences Private Limited · ₹25.87 Cr (FY 2024)
Combined revenue ₹42.38 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Penam Biosciences Private Limited U24304HR2020PTC084593
Director07 Jan 20202020₹25.87 Cr (FY 2024)Active
Protech Remedies Private Limited U21002HR2023PTC112261
Director02 Jun 20232023₹16.51 Cr (FY 2025)Active
S K S Metals Private Limited U27100DL2009PTC194550
Director15 Jan 20212009Active
Zymes Tech Private Limited U33302DL2020PTC367528
Director06 Aug 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner02 Mar 20262026Active
Protech Distribution Private Limited U46497DL2024PTC429682
Director10 Apr 20242024Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Aniket Dhingra

Directorship timeline

Open interactive timeline →
Protech Remedies Private Limited
Penam Biosciences Private Limited
S K S Metals Private Limited
Zymes Tech Private Limited
Premium access

Shareholding and investment profile for Aniket Dhingra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aniket Dhingra

Aniket Dhingra currently holds 4 directorships: Penam Biosciences Private Limited (Director, since 07 Jan 2020, revenue ₹25.87 Cr (FY 2024)); Protech Remedies Private Limited (Director, since 02 Jun 2023, revenue ₹16.51 Cr (FY 2025)); S K S Metals Private Limited (Director, since 15 Jan 2021); Zymes Tech Private Limited (Director, since 06 Aug 2020).

Aniket Dhingra was first appointed on 07 Jan 2020 as Director at Penam Biosciences Private Limited. The most recent appointment on record is 02 Mar 2026 at Emriz Healthcare Llp.

The 2 current companies of Aniket Dhingra that report revenue have a combined latest revenue of ₹42.38 Cr: Penam Biosciences Private Limited ₹25.87 Cr (FY 2024); Protech Remedies Private Limited ₹16.51 Cr (FY 2025).

Aniket Dhingra held 2 earlier board appointments: Emriz Healthcare Llp (Designated Partner, 02 Mar 2026 to 08 May 2026); Protech Distribution Private Limited (Director, 10 Apr 2024 to 01 Jun 2026).

The current boards of Aniket Dhingra's companies include Asha Dhingra (Penam Biosciences Private Limited), Priyanka Aneja (Penam Biosciences Private Limited), Shashi Raj Jajware (Penam Biosciences Private Limited), Chandan Chopra (Zymes Tech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available